View Older Stories

Feb 23, 2026 08:29AM Bristol-Myers Squibb Co. (BMY) PT Raised to $75 at Piper Sandler

Feb 20, 2026 06:00AM Barclays Starts Bristol-Myers Squibb Co. (BMY) at Overweight

Feb 17, 2026 07:00AM FDA accepts Bristol Myers Squibb drug application for multiple myeloma

Feb 13, 2026 03:04PM Bristol-Myers Squibb receives orphan drug designation for lymphoma treatment

Feb 10, 2026 07:44AM Bernstein Weighs In on Bristol-Myers Squibb (BMY) Ahead of H2 Critical Clinical Readouts

Feb 6, 2026 07:30AM Bristol-Myers Squibb Co. (BMY) PT Raised to $72 at Guggenheim

Feb 6, 2026 06:44AM Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Wells Fargo

Feb 5, 2026 03:37PM Truist: 'We remain incrementally positive on BMY'

Feb 5, 2026 07:00AM Bristol-Myers Squibb (BMY) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY26 Guidance

Feb 5, 2026 05:50AM Stocks expected to have increasing option volume: BMY KKR CMI CI CBOE CARR CAH EL HSY TPR RL PTON AMZN MSTR BIIB ALGT MOD M KLIC HP

Feb 4, 2026 06:59AM Bristol Myers Squibb partners with Kasey Keller on lymphoma awareness

Feb 4, 2026 05:37AM Bristol-Myers Squibb (BMY) call put ratio 1.6 calls to 1 put into quarter results

Feb 3, 2026 06:59AM Bristol Myers Squibb launches educational campaign on cardiovascular care

Jan 28, 2026 08:53AM Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Piper Sandler

Jan 22, 2026 07:00AM Bristol Myers Squibb partners with Microsoft on lung cancer AI detection

Jan 22, 2026 07:00AM Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

Jan 20, 2026 06:59AM Bristol Myers Squibb partners with Microsoft on AI lung cancer detection

Jan 13, 2026 04:49AM Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Leerink Partners

Jan 9, 2026 07:33AM Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Scotiabank

Jan 8, 2026 11:26AM Bristol-Myers Squibb (BMY) call put ratio 1.5 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 7, 2026 03:05AM UBS Assumes and Upgrades Bristol-Myers Squibb Co. (BMY) at Buy

Dec 23, 2025 06:47AM Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)

Dec 19, 2025 03:05PM Bristol Myers Squibb strikes deal with US government on drug pricing

Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts

Dec 19, 2025 12:39PM Bristol Myers receives FDA orphan drug designation for systemic sclerosis

Dec 15, 2025 06:43AM BofA Securities Upgrades Bristol-Myers Squibb Co. (BMY) to Buy

Dec 12, 2025 06:10AM Guggenheim Upgrades Bristol-Myers Squibb Co. (BMY) to Buy

Dec 10, 2025 04:17PM Bristol-Myers Squibb (BMY) Raises Quarterly Dividend 1.6% to $0.63; 4.9% Yield

Dec 8, 2025 04:31PM Bristol Myers Squibb presents lymphoma research data at ASH 2025

Dec 5, 2025 06:00AM FDA approves Bristol Myers Squibb Breyanzi for marginal zone lymphoma

Dec 4, 2025 06:49AM Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at Scotiabank

Dec 3, 2025 01:45PM Truist Securities on Bristol-Myers Squibb Co. (BMY): 'overall positive'

Dec 1, 2025 06:59AM Bristol Myers Squibb presents hematology pipeline data at ASH 2025

Nov 26, 2025 06:36AM Bernstein on IRA pricing: $245 really is the floor

Nov 25, 2025 07:12AM Guggenheim Reiterates Neutral Rating on Bristol-Myers Squibb Co. (BMY)

Nov 25, 2025 04:51AM Bristol-Myers Squibb (BMY) call put ratio1.7 calls to 1 put amid price movement

Nov 24, 2025 05:00PM Bristol Myers Squibb gains European approval for Breyanzi in mantle cell lymphoma

Nov 24, 2025 07:01AM Bristol-Myers Squibb's (BMY) Milvexian Can Reset Sentiment - Cantor Fitzgerald

Nov 24, 2025 07:01AM Bristol-Myers Squibb's (BMY) Milvexian Can Reset Sentiment Positively - Cantor Fitzgerald

Nov 20, 2025 08:30AM BMO Capital: 'Bristol-Myers Squibb (BMY) Management Paints a Path Through Near-Term Catalysts'

Nov 18, 2025 02:26PM Bristol Myers Squibb accepts $7.5 billion in debt tender offers

Nov 17, 2025 08:16AM BMO Capital on Bristol-Myers Squibb (BMY): 'LIBREXIA-ACS Discontinuation Places More Weight on Remaining Programs'

Nov 17, 2025 07:30AM Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'

Nov 17, 2025 06:25AM Bernstein on Bristol-Myers Squibb Co. (BMY): 'Key Catalysts Carrying More Risk Than Ever'

Nov 12, 2025 09:06AM Sarah Cannon Research Institute expands collaboration with Bristol Myers Squibb

Nov 10, 2025 07:25AM Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Piper Sandler

Nov 5, 2025 02:47PM Bristol Myers Squibb prices €5 billion senior unsecured notes offering

Nov 3, 2025 08:32AM Bristol Myers Squibb presents CAMZYOS data at heart association meeting

Nov 3, 2025 07:15AM Bernstein on Bristol-Myers Squibb Co. (BMY): 'All Eyes on Cobenfy's ADEPT-2'

Oct 30, 2025 12:56PM Metsera Was Previously in Exclusive Talks with Bristol-Myers Squibb, Sources Say -- WSJ

View Older Stories